BUSINESSMay 26 · 16:28 UTCBLOOMBERG

Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion

Eli Lilly and Company is acquiring three vaccine developers for up to $3.8 billion. The transaction highlights the company's expansion into vaccine development and biotechnology innovation.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Eli Lilly and Companyorganizationvaccine developerstopicJohn McConnicopersonBloomberg Newsorganization

Spot something wrong with this article?Report a problem →

Forward this